CCM
TMO icon

Chiron Capital Management’s Thermo Fisher Scientific TMO Stock Holding History

Chiron Capital Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$915K Buy
1,825
+125
+7% +$60K 0.82% 38
2026
Q1 		$836K Buy
+1,700
New +$923K 0.86% 35
2025
Q3 		$873K Sell
1,800
-600
-25% -$279K 0.75% 41
2025
Q2 		$973K Buy
+2,400
New +$1M 0.85% 40

Other funds holding TMO

Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
LT
Lindsell Train London, United Kingdom $2.63B AUM 2.97% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
CF
Canoe Financial Calgary, Alberta, Canada $8.07B AUM 25.47% 1-Year Est. Return
SP
Sarasin & Partners London, United Kingdom $8.54B AUM 9.6% 1-Year Est. Return
DLA
Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return
PL
Perpetual Ltd Sydney, New South Wales, Australia $7B AUM 19.75% 1-Year Est. Return

Chiron Capital Management's TMO Position: Q2 2026 in Review

Chiron Capital Management increased its Thermo Fisher Scientific (TMO) stake by 7.4% in Q2 2026, buying an estimated $60K and bringing the position to 1,825 shares worth $915K. The position accounts for 0.82% of the portfolio, ranked #38.

Chiron Capital Management first reported a position in TMO in Q2 2025 and has held it in 4 quarters since. The position peaked at $973K in Q2 2025. 568 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Chiron Capital Management held 1,825 shares of Thermo Fisher Scientific worth $915K as of Q2 2026.
  • Chiron Capital Management bought 125 Thermo Fisher Scientific shares in Q2 2026, an estimated $60K.
  • Thermo Fisher Scientific made up 0.82% of Chiron Capital Management's portfolio in Q2 2026, its #38 holding.
  • Chiron Capital Management first reported a position in Thermo Fisher Scientific in Q2 2025 and has held it in 4 quarters since.
  • Chiron Capital Management's Thermo Fisher Scientific position peaked at $973K in Q2 2025.
  • 568 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Chiron Capital Management's 13F filing for Q2 2026, filed 21 Jul 2026.